Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|20|2981-2994

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.20, 2012-07, pp. : 2981-2994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thymidine Phosphorylase Inhibitors: Recent Developments and Potential Therapeutic Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1113-1123

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemistry and Biology of 2'-Fluoro-2'-Deoxythymidine (FT), A Putative Highly Selective Substrate for Thymidine Kinase Type 2 (TK2)

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 1, 2012-01 ,pp. : 38-46

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 306-327

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-02 ,pp. : 232-256

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Thymidine Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 13, 2005-10 ,pp. : 1205-1219

Bentham Science Publishers

Access to resources Recommend Favorite